Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants | Zendy

Margaret C. Fang | Zendy; Alan S. Go | Zendy; Yuchiao Chang | Zendy; Leila H. Borowsky | Zendy; Niela K. Pomernacki | Zendy; Natalia Udaltsova | Zendy; Daniel E. Singer | Zendy

Open Access

Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants

Author(s) -

Margaret C. Fang,

Alan S. Go,

Yuchiao Chang,

Leila H. Borowsky,

Niela K. Pomernacki,

Natalia Udaltsova,

Daniel E. Singer

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.630731

Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , antithrombotic , cardiology , odds ratio , cohort , mechanical engineering , engineering

Prescribing warfarin for atrial fibrillation depends in large part on the expected reduction in ischemic stroke risk versus the expected increased risk of intracranial hemorrhage (ICH). However, the anticoagulation decision also depends on the relative severity of such events. We assessed the impact of anticoagulation on 30-day mortality from ischemic stroke versus ICH in a large community-based cohort of patients with atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research